Koyfin Home > Directory > Health Care > Novocure Ltd Ord Sh > EV / EBITDA (ntm)

Novocure Ltd Ord Sh EV / EBITDA (ntm) Chart (NVCR)

Novocure Ltd Ord Sh annual/quarterly EV / EBITDA (ntm) from 2017 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Novocure Ltd Ord Sh EV / EBITDA (ntm) for the quarter ending November 11, 2020 was 204.04 a -6.07% decrease of -12.39 year over year
  • Novocure Ltd Ord Sh EV / EBITDA (ntm) for the last 12 months ending November 11, 2020 was 204.04 a -6.07% decrease of -12.39 year over year
  • Novocure Ltd Ord Sh Annual EV / EBITDA (ntm) for 2020 was 204.04 a 8.15% increase of 16.63 from 2019
  • Novocure Ltd Ord Sh Annual EV / EBITDA (ntm) for 2020 was 187.41 a -2.38% decrease of -4.47 from 2019
  • Novocure Ltd Ord Sh Annual EV / EBITDA (ntm) for 2020 was 191.88 a -12.79% decrease of -24.55 from 2019
Other Valuation Metrics:
  • Novocure Ltd Ord Sh Market Cap for the quarter ending June 06, 2018 was $2,839m a 37.77% increase of 1,072m year over year
  • Novocure Ltd Ord Sh Price / Book for the quarter ending June 06, 2018 was 26.66 a 43.87% increase of 11.70 year over year
  • Novocure Ltd Ord Sh Enterprise Value for the quarter ending June 06, 2018 was $2,772m a 39.42% increase of 1,093m year over year
View Chart On Koyfin

Quarterly NVCR EV / EBITDA (ntm) Data

11/2020204.04
11/2020187.41
11/2020191.88
11/2020216.43
11/2020213.08
11/2020201.46
11/2020195.65
11/2020196.02
11/2020192.96
11/2020200.18

Annual NVCR EV / EBITDA (ntm) Data

2020204.04
2020187.41
2020191.88
2020216.43
2020213.08
2020201.46
2020195.65
2020196.02
2020192.96
2020200.18